SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-170782
Filing Date
2017-05-15
Accepted
2017-05-15 17:01:53
Documents
46
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d373026d10q.htm 10-Q 271683
2 EX-10.3 d373026dex103.htm EX-10.3 140031
3 EX-31.1 d373026dex311.htm EX-31.1 9377
4 EX-31.2 d373026dex312.htm EX-31.2 9544
5 EX-32.1 d373026dex321.htm EX-32.1 3099
6 EX-32.2 d373026dex322.htm EX-32.2 3277
  Complete submission text file 0001193125-17-170782.txt   1943336

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT pirs-20170331.xml EX-101.INS 228164
8 XBRL TAXONOMY EXTENSION SCHEMA pirs-20170331.xsd EX-101.SCH 28164
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pirs-20170331_cal.xml EX-101.CAL 35725
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pirs-20170331_def.xml EX-101.DEF 72081
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE pirs-20170331_lab.xml EX-101.LAB 217282
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pirs-20170331_pre.xml EX-101.PRE 141316
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37471 | Film No.: 17845459
SIC: 8731 Services-Commercial Physical & Biological Research